The rise of wearable Holter monitors was unmistakable last week at Heart Rhythm 2025, not just in innovation, but in sheer presence. Compared to previous years, there was a marked increase in the number of companies showcasing wearable cardiac monitoring devices. The exhibit hall was packed with vendors unveiling devices featuring lightweight form factors, extended wear durations, and arrhythmia detection algorithms.
The growing field of cardiac monitoring devices reflected a clear momentum: wearable Holter devices are no longer niche tools; they are rapidly becoming the foundation of ambulatory ECG diagnostics. But beneath the innovation lies an often-overlooked truth: while wearable devices offer improved patient comfort and arrhythmia capture rates, they have not resolved workflow challenges, particularly for cardiac teams managing high patient volumes.
The Hidden Operational Cost of Wearables
For many clinicians and cardiac PTs, wearable Holters have simplified patient setup. However, this ease on the front end often comes at the expense of post-test efficiency.Delayed Data Access
Nearly all wearable Holter devices shown at HRS2025, whether from established manufacturers or newer entrants, still require the device to be physically returned before any data can be uploaded, processed, or reviewed. While the extended monitoring period may be 3–14 days, the final report is often not delivered until 5–14 days after the test ends. This delay undermines one of the core goals of arrhythmia monitoring: early diagnosis and prompt treatment.Reusable Devices = Reprocessing Bottlenecks
Reusable Holter devices require manual cleaning, disinfection, and reconfiguration between uses, creating a recurring burden on clinical staff. Just as importantly, these devices must be available and ready at the time of the patient’s appointment. Delays in device turnaround can result in patients waiting in-clinic or needing to return later, negatively impacting both satisfaction and clinic efficiency.Patient Compliance and Logistics
Devices that require physical return rely heavily on patient compliance. Lost shipments or delayed mailings increase the risk of delayed diagnosis and compromised clinical outcomes.Reimagining the Holter Workflow: UbiqVue Holter
Recognizing these growing operational gaps, the UbiqVue 2AYe Holter System was designed from the ground up to streamline not just patient experience—but the entire diagnostic workflow.Same-Day Reporting – No more delays
Once Holter monitoring is complete, ECG data is automatically processed within minutes by cloud-based algorithms. A certified cardiac technician reviews the initial report data and generates a diagnostic report. Clinicians can access, interpret, and e-sign the final Holter report from any location, significantly reducing delays and enabling faster clinical decision-making.Single-Use by Design – No Mail Back or Reprocessing Required
The single-use device combined with the patient-facing app, eliminates the need to return the Biosensor for data extraction. There is no requirement for device disinfection, recharging, or reconfiguration between patients. This approach enhances infection control compliance, reduces turnaround time, and simplifies logistical demands for clinical teams.On-Demand ECG Review – Request Interim Holter Reports Mid-Test
Unlike other Holter monitors, the UbiqVue 2AYe Biosensor transmits ECG data securely via a patient-facing app throughout the monitoring period. Physicians can request and review interim reports, even before the test is complete – supporting timely evaluation and escalation when clinically necessary.The Bigger Picture: Matching Innovation with Efficiency
Wearable Holters have undoubtedly moved the field forward, but as ambulatory cardiac monitoring scales to broader populations and supports community remote monitoring health programs, efficiency across the full diagnostic cycle becomes critical. The future of Holter monitoring won’t be defined by device wearability alone – it will be defined by how quickly and efficiently data can be captured, analyzed, reviewed, and acted upon. UbiqVue Holter bridges that gap, offering clinical-grade 2-channel ECG with the operational fluidity required by today’s clinical teams.
